网站大量收购独家精品文档,联系QQ:2885784924

肾动脉狭窄支架术现状课件_1.ppt

  1. 1、本文档共54页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
肾动脉狭窄支架术现状课件_1

Renal stenting in renal artery stenosis ----contented and uncontented 肾 动 脉狭窄支架术 ARAS 90% FMD 10% Haemodynamics:  50% Renal perfusion pressure reduction  70% RPP75-85mmHg, autonomic regulation lose  Pathology: Glomcrulus:arteriosclerosis, mesenterium proliferation, Nephric tubule:epithelial cells denudation、apoptosis,Focal necrosis, Renal interstitium:Inflammatory cell infiltration、fibrocyte proliferation End stage :renal atrophy Develop to total occlusion within 5 years 15% Deterioration gradually within 5 years 10-20% Develop to ESRD annually 5-15% 3-year mortality in Pt. with ESRD on dislysis 50% Survival of ARAS Pt. with ESRD on dislysis: 5-year 18% 10-year 5% Renal function: improement: GFR increse 15% /Scr decrease 0.2mg/dL stable: GFR change15% / Scr change 0.2mg/dL ineffective: GFR decrease 15% / Scr increase 0.2mg/dL benefit: Improement or stable Blood pressure: cure: SBP140mmHg and DBP90mmHg, without any anti-hypertension drugs, improement: SBP140mmHg and DBP90mmHg, or, DBPdecrease 15mmHg with similar or less anti-hypertension drugs ineffective: BP change not meet the above standard benefit: cure and improvement nephron redunction volume-dependent hypertension:(Bil RAS/renal dysfunction) renin-dependent hypertension:(uni RAS) sympathetic nervous system vasoactive substance secreted from kidney:natriuretic hormone vasopressin Renal arteriolar sclerosis in benign hypertension Early stage:hyalinization in afferent glomerular arteriole and arteria interlobulares advanced stage:glomerulus, nephri

文档评论(0)

sanshengyuan + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档